Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Gains from Investment Securities (2019)

Historic Gains from Investment Securities for AC Immune (ACIU) over the last 1 years, with Q3 2019 value amounting to -$9.2 million.

  • AC Immune's Gains from Investment Securities changed N/A to -$9.2 million in Q3 2019 from the same period last year, while for Dec 2019 it was -$13.7 million, marking a year-over-year change of. This contributed to the annual value of -$14226.5 for FY2021, which is 12084.71% down from last year.
  • AC Immune's Gains from Investment Securities amounted to -$9.2 million in Q3 2019.
  • Over the past 5 years, AC Immune's Gains from Investment Securities peaked at $35903.1 during Q2 2019, and registered a low of -$9.2 million during Q3 2019.